Pharmaceutical
Blincyto : Orphan maintenance assessment report (post-authorisation) (II-0030)
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Dosage
Blincyto : Orphan maintenance assessment report (post-authorisation) (II-0030)
Strength
Blincyto : Orphan maintenance assessment report (post-authorisation) (II-0030)
Pack Size
Blincyto : Orphan maintenance assessment report (post-authorisation) (II-0030)
Form
Blincyto : Orphan maintenance assessment report (post-authorisation) (II-0030)
Safety Profile
Contraindications
Blincyto : Orphan maintenance assessment report (post-authorisation) (II-0030)
Side Effects
Blincyto : Orphan maintenance assessment report (post-authorisation) (II-0030)
Scan this QR code to access this page quickly on your mobile device.